Literature DB >> 27769847

Incomplete KLK7 Secretion and Upregulated LEKTI Expression Underlie Hyperkeratotic Stratum Corneum in Atopic Dermatitis.

Satomi Igawa1, Mari Kishibe2, Masako Minami-Hori2, Masaru Honma2, Hisashi Tsujimura3, Junko Ishikawa4, Tsutomu Fujimura4, Masamoto Murakami5, Akemi Ishida-Yamamoto2.   

Abstract

Atopic dermatitis (AD) is a common inflammatory skin disorder. Chronic AD lesions present hyperkeratosis, indicating a disturbed desquamation process. KLK7 is a serine protease involved in the proteolysis of extracellular corneodesmosome components, including desmocollin 1 and corneodesmosin, which leads to desquamation. KLK7 is secreted by lamellar granules and upregulated in AD lesional skin. However, despite increased KLK7 protein levels, immunostaining and electron microscopy indicated numerous corneodesmosomes remaining in the uppermost layer of the stratum corneum from AD lesions. We aimed to clarify the discrepancy between KLK7 overexpression and retention of corneodesmosomes on AD corneocytes. Western blot analysis indicated abnormal corneodesmosin degradation patterns in stratum corneum from AD lesions. The KLK activity of tape-stripped corneocytes from AD lesions was not significantly elevated in in situ zymography, which was our new attempt to detect the protease activity more precisely than conventional assays. This ineffective KLK activation was associated with impaired KLK7 secretion from lamellar granules and increased expression of LEKTI in AD. Such imbalances in protease-protease inhibitor interactions could lead to abnormal proteolysis of corneodesmosomes and compact hyperkeratosis. Upregulated expression of LEKTI might be a compensatory mechanism to prevent further barrier dysfunction in AD.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27769847     DOI: 10.1016/j.jid.2016.10.015

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

Review 1.  Atopic dermatitis: molecular, cellular, and clinical aspects.

Authors:  Jafar Salimian; Zahra Salehi; Ali Ahmadi; Alireza Emamvirdizadeh; Seyyed Masoud Davoudi; Mehrdad Karimi; Mohsen Korani; Sadegh Azimzadeh Jamalkandi
Journal:  Mol Biol Rep       Date:  2022-01-06       Impact factor: 2.316

Review 2.  Revisiting the Roles of Filaggrin in Atopic Dermatitis.

Authors:  Verena Moosbrugger-Martinz; Corinne Leprince; Marie-Claire Méchin; Michel Simon; Stefan Blunder; Robert Gruber; Sandrine Dubrac
Journal:  Int J Mol Sci       Date:  2022-05-10       Impact factor: 6.208

Review 3.  Break on through: The role of innate immunity and barrier defence in atopic dermatitis and psoriasis.

Authors:  H C Hawerkamp; C M R Fahy; P G Fallon; C Schwartz
Journal:  Skin Health Dis       Date:  2022-02-16

4.  Staphylococcus aureus binds to the N-terminal region of corneodesmosin to adhere to the stratum corneum in atopic dermatitis.

Authors:  Aisling M Towell; Cécile Feuillie; Pauline Vitry; Thaina M Da Costa; Marion Mathelié-Guinlet; Sanja Kezic; Orla M Fleury; Maeve A McAleer; Yves F Dufrêne; Alan D Irvine; Joan A Geoghegan
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-05       Impact factor: 11.205

5.  Therapeutic effects of quinine in a mouse model of atopic dermatitis.

Authors:  Qian Zhang; Hongjing Jiang; Miao Liu; Xinchen Li; Murong Zhou; Yansi Lyu; Jingkai Huang; Si Chen; Li Wang
Journal:  Mol Med Rep       Date:  2021-07-09       Impact factor: 2.952

6.  NFAT5 Controls the Integrity of Epidermis.

Authors:  Khalid Muhammad; Delicia Xavier; Stefan Klein-Hessling; Muhammad Azeem; Tabea Rauschenberger; Krisna Murti; Andris Avots; Matthias Goebeler; Matthias Klein; Tobias Bopp; Malte Sielaff; Stefan Tenzer; Sigrid Möckel; José Aramburu; Cristina López-Rodríguez; Andreas Kerstan; Edgar Serfling
Journal:  Front Immunol       Date:  2021-12-09       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.